TRON MERGER DD with Filing
This is a combined TRON MERGER DD post comprised of DD researched and found by investors on this board. SMITTER, HOKIEHEAD, BGALLATIN, MVIR and others, thank you for your contribution and help to everyone.
RECENT PRESS RELEASE: TRON NEWS AUG 19TH 2016
TORON, INC (OTC: TRON) PROVIDES CORPORATE UPDATE REGARDING
PENDING MERGER WITH IMEDSCAN CORPORATION
Toron Inc. to Merge With Disruptive Healthcare Technology Company
MIAMI BEACH, FLORIDA – August 17, 2016 - Toron, Inc (OTC Pink: TRON) provided its stockholders today with a corporate update regarding the pending merger with private company, iMedScan Corporation. Pursuant to the definitive Agreement and Plan of Merger entered into on March 30, 2016 iMedScan will become public through an alternative public offering or “APO” transaction with Toron. On March 21, 2016, in anticipation of the closing of the merger transaction during the third quarter of 2016, Fabrizio Bosticco, the Chief Executive Officer of iMedscan, was also named Chief Executive Officer, President and Director of Toron. iMedican is a healthcare project development and management company holding a proprietary technology that provides for the instant verification of a patient’s medical insurance. “iMedcan’s proprietary technology will generate a twenty-five (25%) reduction in patient insurance rejections or denials from insurance payors,” Bostico said. He continued, “changes in the healthcare industry have considerably lowered profit margins and increase the costs of healthcare to consumers; we believe our technology will create significant cost reductions that will benefit both insurers and insureds.” In March, 2016, iMedScan entered into an agreement with Acuant Corporation of Los Angeles, California to employ its proprietary, hosted scanning solution on patient’s driver’s licenses and insurance cards. Most recently, in June, 2016, iMedScan finalized a test program with Change America, formerly Emdeon Corpoation, utilizing an electronic data interchange for verifying and validating patients’ health insurance. “We estimate a fifty (50%) percent net profit recapture from each medical office that adopts our technology,” Bostico noted. Currently, in addition to traditional medical offices, iMedScan is focusing on the further development and commercialization of kiosk devices hosting the company’s scanning solution.
About Toron, Inc. & iMedScan Corporation On March 30, 2016, Toron, Inc. entered into an definitive Agreement and Plan of Merger with iMedScan corporation, pursuant to which, upon closing, iMedScan will become a wholly-owned subsidiary of Toron. iMedscan Corporation is an innovative disruptive healthcare technology company focused on integrating access to electronic data interfaces (“EDI”) for healthcare providers and payor systems in a user friendly manner. iMedScan’s technology provides ease of use for patients by simplifying their check-in registration process, while at the same time reducing the healthcare providers’ administrative expenses and lost revenues by eliminating insurance rejections, denials or any incorrect results arising from erroneous or incomplete patient information verification. iMedScan’s proprietary iMedScan Connect and iMedScan EDI technologies will combine to create strong, recurring revenue for the company. Statements in this press release that are not historical fact may be deemed forward looking
statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although Toron, Inc believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, Toron is unable to give any assurance
that its expectations will be attained. Factors that could cause actual results to differ materially from expectations include the company’s ability meet the conditions necessary to, among other matters, obtain a public listing on a major national exchange.
###
Contact:
Pacifix Financial, LLC
Tel. (630) 854-7942
at@pacifixfinancial.com
LINK TO IMED WEBSITE
https://imedscan.com/
LINK TO TORON'S FUTURE WEBSITE
http://toroninc.com/
LINK TO ACUANT WEBSITE
http://www.acuantcorp.com/
LINK TO CHANGE HEALTHCARE WEBSITE
http://changehealthcare.com/
SUPPLEMENTAL INFO ON CHANGE HEALTHCARE PR SEP 3RD 2015
http://www.prnewswire.com/news-releases/emdeon-to-rebrand-as-change-healthcare-300137812.html
QUICK TIDBIT ON CHANGE HEALTHCARE'S PR BACK IN SEPTEMBER
The company's Intelligent Healthcare Network is the single largest financial and administrative healthcare network in the United States, reaching approximately 750,000 physicians, 105,000 dentists, 60,000 pharmacies, 5,000 hospitals, 600 vendors, 450 laboratories and 1,200 government and commercial payers, and allows the company to bring actionable data, analytics and insights to the healthcare ecosystem. The company's network processed approximately 8.1 billion healthcare-related transactions, covering $1.2 trillion in claims, in 2014. The company has developed this network of payers and providers over 30 years and connects to virtually all private and government payers, claim-submitting providers and pharmacies in a hybrid cloud-based, user-centric and secure infrastructure environment.
LINKS TO WHAT AN APO IS AND IT'S PROCESS
http://www.slideshare.net/ClintonGreyling/ipo-vs-apo
https://en.wikipedia.org/wiki/Alternative_public_offering
EXAMPLES OF COMPANIES THAT COMPLETED AN APO
Valeritas Holdings, Inc. (OTCQB: VLRX) announced today its successful completion of an alternative public offering (APO). This was accomplished via a reverse merger of its wholly owned operating company, Valeritas, Inc. and a private placement of approximately 5 million shares of its unregistered common stock at $5.00 per share.
http://news.sys-con.com/node/3796621
June 08, 2016
Miramar Labs, Inc. Completes APO, Raises $9.0 Million
https://globenewswire.com/news-release/2016/06/08/846990/0/en/Miramar-Labs-Inc-Completes-Alternative-Public-Offering-Raises-9-0-Million.html
Currently $5
http://www.otcmarkets.com/stock/MRLB/quote
May 04, 2016
Valeritas Completes APO and Raises Gross Proceeds of $25.2 Million
http://www.prnewswire.com/news-releases/valeritas-completes-alternative-public-offering-and-raises-gross-proceeds-of-252-million-578078911.html
Currently $5
http://www.otcmarkets.com/stock/VLRX/quote
Alternative Public Offerings are likely to push more private and successfully crowdfunded businesses into the public markets
http://www.growvc.com/blog/2014/11/how-crowdfunding-will-grease-the-skids-for-alternative-public-offerings/
OTHER EXAMPLES
Miramar Labs, they did an APO, they were trading at $0.51 then they announced the APO that had a $9 million placement for 1.8 million shares. (9/1.8 = $5). The stock traded for $5 and has held above that.
Also look at ONVO, they did an APO, they were trading for pennies on the OTC then announced $6.5 million placement for 22.4 million shares. They opened at $1.65 and hit $10+ in 4 months and now are on Nasdaq.
In 2016 VLRX was trading for pennies under CYGM then announced $25 million placement for 5 million shares at $5 a share. They opened up at $6 and are trading $5-$6. Had you owned the CYGM shares you banked huge.
EKSO did a huge APO,
http://ir.eksobionics.com/press-releases/detail/114/robotic-exoskeleton-innovator-ekso-bionics-goes-public
They opened at $2.50 and hit a high of $8 less than a month later and is now on Nasdaq.
Look at ENUM, good explanation here:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124160410
PARAGRAPH ON TRON'S 15-C STATING A REVERSE SPLIT
1.13 Split of TRON Shares. Immediately prior to the Closing Date, TRON will split the issued and outstanding TRON Shares such that the TRON Shares issued and outstanding immediately prior to the Effective Time shall equal approximately 6% of the total amount of issued and outstanding shares immediately after the Effective Time, calculated on a Fully Diluted Basis or 1,500,000 shares, whichever is greater. For the purposes of this Agreement, the term “Fully Diluted Basis” shall include all issued and outstanding shares of capital stock of TRON and all shares of capital stock issuable upon conversion of all TRON Convertible Securities, but shall exclude all options to purchase any class of capital stock of TRON that have not yet vested as of the Closing Date. Immediately prior to the Effective Time there shall be 745,589,316 TRON Shares issued and outstanding, subject to adjustment as provided above. The calculation of the split of the TRON Shares and the TRON Shares to be issued as Total Merger Consideration is set forth in Exhibit C.
PARAGRAPH ON MERGER CONSIDERATION: CONVERSION OF SHARES
1.4 Merger Consideration; Conversion of Shares. The total consideration to be paid to the Company Shareholders in connection with the Merger (the “Total Merger Consideration”) shall be issuance of up to 25,0000,000 restricted shares on a 25,000 for 1 basis of TRON Common Stock, par value $0.001 per share (the “TRON Shares”), to the Company Shareholders on the Closing Date. Subject to the provisions of this Agreement, at the Effective Time, by virtue of the Merger and without any action on the part of the Company Shareholders, the Company, TRON or the TRON Subsidiary, each outstanding share of Common Stock of the Company shall be converted into the right to receive a pro rata amount of TRON Shares.
Investor's, other than this post, please read the other posts made from this board and conduct your own DD. If you have any questions, myself and everyone here can assist.
News 
Market Data 
Discover 
